Pre-analytical long-term stability of neopterin and neurofilament light in stored cerebrospinal fluid samples
Author:
Rosadas Carolina1ORCID, Taylor Graham P.12
Affiliation:
1. Section of Virology, Department of Infectious Disease , Imperial College London , London , UK 2. National Centre for Human Retrovirology , St Mary’s Hospital , London , UK
Abstract
Abstract
Objectives
The aim of this study was to evaluate the impact of long-term sample storage on the concentrations of neopterin and neurofilament light (Nfl) in cerebrospinal fluid (CSF) samples. These are useful markers of neuroinflammation and neuronal damage and have been applied as biomarkers for several neurological diseases. However, different pre-analytical variables have potential to influence results.
Methods
Twenty-one CSF samples donated by patients with HTLV-1-associated myelopathy (HAM) and stored for up to 11 years at −80 °C were retested after three-years for neopterin (n=10) and Nfl (n=11) by ELISA.
Results
There was a strong correlation between the paired results (r>0.98, p<0.0001). Neopterin concentrations (nmol/L) ranged from 12.4 to 64 initially and from 11.5 to 64.4 when retested, with means (SD) of 30 (18.4) 1st test and 33 (19.1) 2nd test. Nfl concentrations (pg/mL) ranged from 79.9 to 3,733 initially and from 86.3 to 3,332, when retested with means (SD) of 1,138 (1,272) 1st test and 1,009 (1,114) at re-test.
Conclusions
Storing CSF samples at −80 °C appears not to impact the quantification of neopterin and Nfl allowing confidence in the reporting of archived samples.
Funder
Internal funding Section of Virology, Imperial College London GPT is supported by the National Institute of Health Research Imperial Biomedical Research Centre
Publisher
Walter de Gruyter GmbH
Subject
Biochemistry (medical),Clinical Biochemistry,General Medicine
Reference20 articles.
1. Califf, RM. Biomarker definitions and their applications. Exp Biol Med 2018;243:213–21. https://doi.org/10.1177/1535370217750088. 2. Carreras, N, Arnaez, J, Valls, A, Agut, T, Sierra, C, Garcia-Alix, A. CSF neopterin and beta-2-microglobulin as inflammation biomarkers in newborns with hypoxic-ischemic encephalopathy. Pediatr Res 2022. https://doi.org/10.1038/s41390-022-02011-0 [Epub ahead of print]. 3. Sato, T, Yagishita, N, Tamaki, K, Inoue, E, Hasegawa, D, Nagasaka, M, et al.. Proposal of classification criteria for HTLV-1-associated myelopathy/tropical spastic paraparesis disease activity. Front Microbiol 2018;9:1651. https://doi.org/10.3389/fmicb.2018.01651. 4. Barco, A, Orlando, S, Stroffolini, G, Pirriatore, V, Lazzaro, A, Vai, DD, et al.. Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders. J Neurovirol 2022;28:226–35. https://doi.org/10.1007/s13365-021-01047-y. 5. Rubach, MP, Mukemba, JP, Florence, SM, Lopansri, BK, Hyland, K, Simmons, RA, et al.. Cerebrospinal fluid pterins, pterin-dependent neurotransmitters, and mortality in pediatric cerebral malaria. J Infect Dis 2021;224:1432–41. https://doi.org/10.1093/infdis/jiab086.
|
|